Literature DB >> 902587

[Regional suppurative lymphadenitis after BCG vaccination (author's transl)].

W Brehmer, N Falkenberg, H Hussels, H S Otto, H Preussler, J Waldschmidt.   

Abstract

In the first half of 1975 there occurred in the Federal Republic of Germany an unusual rise in the incidence of suppurative inguinal lymphadenitis after BCG vaccination of newborns, in immediate time relation with change of the vaccine by its manufacturers, Behringwerke. The attenuated daughter strain Göteborg had been replaced by the effective but also rather aggressive strain Copenhagen 1331. The complication rate was 1.5% in West Berlin. Clinical course, operative technique as well as microbiological and histomorphological features of these cases were analyzed in a joint study. Since it is likely that, after re-admission of the Copenhagen vaccine, such complications may again occur despite reduced micro-organism count, vaccination of newborns should in future be restricted to those at risk.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 902587     DOI: 10.1055/s-0028-1105489

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  Neonatal hyperimmune T-cell reaction mimicking T-cell non-Hodgkin's lymphoma following BCG and hepatitis B co-vaccination.

Authors:  Snjezana Dotlic; Semir Vranic; Gordana Jakovljevic; Ivana Ilic; Mirjana M Kardum-Paro; Stefan D Dojcinov
Journal:  Virchows Arch       Date:  2012-09-12       Impact factor: 4.064

2.  Occurrence of suppurative lymphadenitis after a change of BCG vaccine.

Authors:  P Hengster; J Schnapka; M Fille; G Menardi
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.